Intellia Corp (NTLA) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Intellia Therapeutics (NTLA) genom tahrirlash orqali zamonaviy davolash usullarini ishlab chiqmoqda, biroq patent nizolari va test natijalariga oid noaniqliklarga duch kelmoqda. Geopolitik fragmentatsiya va sanksiyalar biomateriallar logistikasi hamda global tadqiqotlarni murakkablashtirmoqda. Shu bilan birga, biznes avtonom talab sikliga tayanadi va retsessiya davrida himoya aktiv bo'lib qoladi. GURU.Markets grafigidagi chiziqli narx harakati ushbu ma'lumotlarni tasdiqlaydi, bunda ko'rsatkich 0.07 darajasida turibdi.
Intellia Therapeutics (NTLA) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Intellia Therapeutics|NTLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati intelliatx.com|NTLA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Intellia Therapeutics, Inc.|NTLA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Intellia Therapeutics|Tezkor likvidlik intelliatx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:NTLA (Intellia Therapeutics Inc)
Ushbu koeffitsiyent uzoq muddatli to'lov qobiliyatini baholash uchun bir yildan ortiq muddatga ega majburiyatlarni kapital bilan solishtirish orqali moliyaviy leveraj darajasini belgilaydi. Joriy uzoq muddatli qarzning kapitalga nisbati Intellia Therapeutics (NTLA) uchun juda muhimdir, chunki ushbu biotexnologiya gigantining tijorat mahsulotlari yo'qligi va operatsion zararlari uni klinik sinovlarni moliyalashtirish uchun tashqi qarz mablag'lariga bog'liq qiladi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRISPR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati GeneDx Holdings WGS|Ultragenyx Pharma (RARE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BEAM|Uzoq muddatli qarzning o'z kapitaliga nisbati SRPT|TWST (twistbioscience.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TXG|STOK - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BioLife Corp BLFS|Wave Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|MAZE - Uzoq muddatli qarzning o'z kapitaliga nisbati|SION: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRME: Uzoq muddatli qarzning kapitalga nisbati|TSHA - Uzoq muddatli qarzdorlikning kapitalga nisbati|QURE (uniQure Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati MeiraGTx Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati RGNX (REGENXBIO Inc.)|SLDB (solidbio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Ocugen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati PACB (Pacific Biosciences of California, Inc.)|Benitec - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti DSGN (Design Corp)|RCKT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati 4dmoleculartherapeutics.com (FDMT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Lexeo Therapeutics Inc.|KRRO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati EDIT|Uzoq muddatli qarzning kapitalga nisbati Silence Therapeutics Corp (SLN)|Uzoq muddatli qarzning o'z kapitaliga nisbati ProQR Therapeutics PRQR|CDXS (Codexis Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Sangamo Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Nautilus Biotechnology|MGX (Metagenomi, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precision BioSciences Inc. (DTIL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati GBIO|BOLD (boundlessbio.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati XCUR|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com|Uzoq muddatli qarzning kapitalga nisbati PHIO (Phio Pharmaceuticals Corp.)|MBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Bionano Genomics, Inc. BNGO|Applied DNA Sciences, Inc. (APDN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BLUE|Uzoq muddatli qarzning o'z kapitaliga nisbati IPA|OMGA (Omega Therapeutics Corp) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|Uzoq muddatli qarzning o'z kapitaliga nisbati RGLS (regulusrx.com)|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TRACON - Uzoq muddatli qarzning kapitalga nisbati|UBX (Unity Biotechnology, Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi